FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 83 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $186,000 | -75.8% | 61,119 | -81.1% | 0.00% | -100.0% |
| Q2 2019 | $770,000 | +1084.6% | 323,600 | +1759.8% | 0.00% | – |
| Q1 2019 | $65,000 | -91.0% | 17,400 | -88.8% | 0.00% | -100.0% |
| Q2 2017 | $719,000 | +134.2% | 154,900 | +149.8% | 0.00% | – |
| Q1 2017 | $307,000 | -70.3% | 62,014 | -38.5% | 0.00% | -100.0% |
| Q2 2015 | $1,033,000 | – | 100,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4,781,708 | $24,530,000,000 | 3.64% |
| Opaleye Management Inc. | 950,000 | $4,873,000 | 1.39% |
| DSC Advisors, L.P. | 1,187,604 | $6,092,000 | 1.28% |
| DAFNA Capital Management LLC | 335,500 | $1,721,000 | 0.84% |
| Vivo Capital, LLC | 855,000 | $4,386,000 | 0.62% |
| Stonepine Capital Management, LLC | 129,756 | $666,000 | 0.36% |
| Eversept Partners, LP | 107,500 | $551,475 | 0.26% |
| Tekla Capital Management LLC | 930,398 | $4,773,000 | 0.19% |
| Perceptive Advisors | 1,117,324 | $5,732,000 | 0.16% |
| Crestline Management, LP | 217,670 | $1,117,000 | 0.14% |